GHK-Cu
Research OnlyAlso known as: Copper Peptide GHK, Glycyl-L-Histidyl-L-Lysine:Copper
A naturally occurring copper-binding tripeptide with wound healing and skin regeneration properties. Extensively studied globally with moderate-to-high evidence for cosmetic applications.
Research Statistics
Moderate human data across multiple countries; copper-peptide mechanism well-characterized.
Research Dossier
Overview
What is GHK-Cu and what does the research say?
Mechanism of Action
GHK-Cu is a naturally occurring tripeptide that acts as a master regulator of tissue repair and regeneration. It is released from damaged collagen and serves as a signaling molecule that coordinates healing processes.
How It Works (Simplified)
GHK-Cu functions as a naturally occurring repair signal through several pathways:
Delivers copper to enzymes like lysyl oxidase that crosslink collagen fibers, making them stronger - like rebar reinforcing concrete.
Stimulates fibroblasts to produce up to 70% more collagen in lab studies, restoring skin structure and firmness.
Modulates expression of 4,000+ genes, resetting DNA activity toward a healthier, more youthful pattern.
Neutralizes reactive oxygen species and detoxifies lipid peroxidation products, protecting cells from oxidative damage.
Scientific Pathways
Wound Healing Cascade
Tissue Injury → SPARC releases GHK from collagen → GHK-Cu acts as chemoattractant
↓
Mast cells, macrophages, fibroblasts recruited
↓
Collagen synthesis via TGF-beta pathway
↓
Lysyl oxidase crosslinks collagen (Cu2+ required)Key Research: Pickart L et al. demonstrated gene modulation affecting 4,000+ genes. PMC6073405
Important Limitations
- Most evidence is for topical cosmetic use, not systemic administration
- Short plasma half-life (~30 minutes) limits systemic applications
- Poor skin penetration without advanced delivery systems
- Plasma levels decline with age: ~200 ng/mL at age 20 to ~80 ng/mL at age 60
- Not FDA-approved as a drug; regulated as a cosmetic ingredient
Evidence-Chained Benefits
Evidence-Chained Benefits
Research findings linked to mechanisms and clinical outcomes
What to Expect
Timeline based on observations from published studies. Individual responses may vary.
Based on cosmetic studies: Early effects on skin hydration and texture may begin. Gene expression changes in skin cells occur within days. Initial wound healing acceleration observed in preclinical models.
Studies show improvements in skin thickness and collagen production beginning at 2-4 weeks of consistent topical use. Anti-inflammatory effects may reduce skin irritation.
Clinical studies showed statistically significant improvements in skin firmness, fine lines, and photodamage after 12 weeks of twice-daily application. Collagen remodeling effects become more apparent.
Continued use may maintain improvements. Studies suggest ongoing benefits for skin quality. Long-term topical safety appears favorable based on available data.
Research-Based Observations
This timeline reflects observations from published clinical and preclinical studies. Individual responses may vary significantly. This is not a guarantee of effects or a dosing schedule. Consult qualified healthcare providers for personalized guidance.
Quality Checklist
Visual indicators to help evaluate GHK-Cu product quality
Good Signs (6 indicators)
Warning Signs (5 indicators)
Bad Signs (7 indicators)
For Research Evaluation Only
These quality indicators are general guidelines based on typical peptide characteristics. Professional laboratory testing (HPLC, mass spectrometry) provides definitive quality verification. This checklist is for initial visual evaluation only.
Peptide Interactions
Known and theoretical interactions when combining GHK-Cu with other peptides. Based on published research and mechanistic considerations.
BPC-157
SynergisticComplementary wound healing mechanisms - BPC-157 targets systemic tissue repair while GHK-Cu promotes collagen synthesis and skin regeneration.
TB-500
CompatibleBoth promote tissue repair through different pathways - TB-500 via actin regulation, GHK-Cu via collagen synthesis and copper-dependent enzymes.
Thymosin-Alpha-1
CompatibleImmunomodulatory effects of thymosin alpha-1 may complement GHK-Cu's wound healing properties, particularly in immunocompromised wound healing.
Epithalon
CompatibleBoth peptides are studied for anti-aging effects through different mechanisms - GHK-Cu via collagen/gene expression, epithalon via telomerase.
LL-37
CompatibleLL-37's antimicrobial properties may complement GHK-Cu's wound healing effects, providing infection control while tissue regenerates.
Research Note: Interaction data is based on published literature, mechanistic understanding, and theoretical considerations. Most peptide combinations lack direct clinical study. This information is for educational purposes only and does not constitute medical advice. Always consult qualified healthcare providers.
References
Key Studies Cited
Full reference list available on request. All citations link to PubMed for verification.
Methodology Note
This dossier synthesizes available evidence from peer-reviewed literature, regulatory documents, and clinical trial registries. Evidence strength ratings follow a modified GRADE approach.
For complete methodology details, see our Methodology page.
Important Disclaimer
This dossier is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.
Get Research Alerts
New dossiers and major study summaries delivered to your inbox. Evidence-graded, citation-backed research you can trust.
No spam. Unsubscribe anytime.
Compare GHK-Cu
GHK-Cu Calculators
Related Peptides
Cartalax
AED peptide, Ala-Glu-Asp, cartilage bioregulator
A synthetic tripeptide (Ala-Glu-Asp) from Vladimir Khavinson's bioregulator framework, proposed to support cartilage tissue repair and chondrocyte function. All research originates from Russian institutes with no independent Western validation or controlled human clinical trials.
GHK
Glycyl-Histidyl-Lysine, GHK tripeptide, Liver cell growth factor
A naturally occurring tripeptide (Gly-His-Lys) with copper-binding affinity and wound healing properties. The base form of GHK without added copper. Endogenous to human plasma where it circulates bound to copper. Declines with age. Most research focuses on the copper-complexed form (GHK-Cu), making evidence for GHK alone limited. Primarily relevant as the precursor to GHK-Cu.
Sigumir
Cartilage cytamin, Joint peptides, A-6 cartilage peptides
A cytamin-class peptide supplement derived from cartilage tissue, part of the Russian bioregulator framework. Marketed as an oral supplement for joint and cartilage support. Contains peptide complexes rather than defined sequences. No Western clinical validation.
TB-500
Thymosin Beta-4 Fragment, TB4-FRAG, TMSB4X
A synthetic fragment of thymosin beta-4 marketed for tissue repair. While the parent compound has Phase 3 clinical research (RGN-259), TB-500 specifically has no published human data.